Skip to main content

Dr. Khan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Khan's full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Radiation Oncology, 1995 - 1998
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Internal Medicine, 1994 - 1995
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1994
  • Pomona College
    Pomona CollegeB.A., Psychooncology, 1985 - 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2023
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2014
  • Yearlong Post-Sophomore Fellowship in Anatomic Pathology 1991
  • Summer Research Fellowship in Otolaryngology 1990
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reduction in Patient-reported Acute Morbidity in Prostate Cancer Patients Treated with 81-Gy Intensity Modulated Radiotherapy Using Reduced Planning Target Volume Marg...  
    Sandler HM, Liu P, Dunn R, Khan DC, Tropper S, Sanda M, Mantz CA, Urology, 1/1/2010
  • Preliminary results and evaluation of MammoSite balloon brachtherapy for partial breast irradiation for pure ductal carcinoma in-situ: a phase II clinical study  
    Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keish M, Dipetrillo T, Khan D, Hudes R, Am J Surgery, 1/1/2006
  • Targeting For Cure: Intensity Modulated Radiation Therapy Current Status and Future Directions in the Treatment of Prostate Cancer  
    Lisa M Chaiken, Michael L Steinberg, Afshin Safa, David Khan, Robert Kwon, & Uri Zisblatt, PCRI Insights, 1/1/2004
  • Join now to see all

Abstracts/Posters

  • Efficiency and Clinical Workflow of Delivering 81 Gy IMRT to the Prostate Within 2 mm Tolerances
    Tropper S, Khan D, Mantz C, American Society of Radiation Oncology, 1/1/2009
  • Development of Otic Capsule Lesions in the Palmerston North Autoimmune Strain Mouse
    Khan DC, Morton JI, Trune DS, Annual Meeting of the American Academy of Otolaryngology, 1/24/1991

Lectures

  • Patient-Reduction in Acute GU and GI Side Effects for Prostate Cancer Patients Treated with 81Gy IMRT Using Reduced PTV Margins and Electromagnetic Tracking 
    1/1/2009
  • Preliminary results and evaluation of Mammosite balloon Brachytherapy for partial breast irradiation for pure ductal carcinoma in- situ: A phase II clinical study 
    1/1/2006
  • Prophylactic Post-Operative Antibiotics for Prostate Brachytherapy: Is it necessary? 
    1/1/2006

Hospital Affiliations